Zhongnan Medical Journal Press

Home Results

A total of 7 result was found. Results that relate to Jin LI

Study on the correlation between c-reactive protein, albumin and c-reactive pro-tein/albumin ratio with disease activity of ulcerative colitis

Published on New Medicine 2021,31(1):336-341.
14099 times 4438 times

Gulibusidan·Wushoer Jian SHANG Jin LI

Ulcerative colitis C-reactive protein/albumin ratio Disease activity
Details
Case report of hypochondriac tendency in COVID-19 epidemic

Published on New Medicine 2020,30(1):476-481.
25332 times 3982 times

Qiang XIONG Jin LI

Hypochondriac tendency Cognitive behavioral therapy COVID-19
Details
Nursing experience of treating a critical ill patient with novel coronavirus (2019-nCoV) infected pneumonia by using ECMO

Published on New Medicine 2020,30(1):74-77.
18491 times 5779 times

Jing MA Fen HU Hui-Min SUN Jie CHEN Xin-Bo DING Jin LI

2019-nCoV COVID-19 Virus pneumonia ECMO Intensive care Nursing
Details
Clinical practice of drug abnormal early warning based on dynamic monitoring of clinical pharmacists

Published on Chinese Journal of Pharmacoepidemiology 2023,32(11):1225-1230.
8245 times 2138 times

Ting-Ting ZHENG Jin LI Lu MAO Ning CHEN Wei ZHANG Jian-Cun ZHEN

Rational drug use Abnormal early warning Dynamic monitoring Clinical pharmacist
Details
Application of nurses specialist-led whole-course home health management model in patients with coronary heart disease after PCI

Published on New Medicine 2024,34(2):129-136.
12713 times 3317 times

JIN Liping XU Jing SHEN Lan

Coronary heart disease Percutaneous coronary intervention Specialist nurse Self-management ability Health-related behavior
Details
Application value of amlodipine/atorvastatin combined with evidence-based emotional nursing mode in elderly patients with hypertension complicated by coronary heart disease

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1048-1054.
10849 times 1733 times

WU Xiangna JIN Liya LIANG Pingping LIN Duoduo ZHENG Wenxian

Amlodipine/atorvastatin Evidence-based emotional nursing mode Hypertension Coronary heart disease Elderly Compliance
Details
Cost-effectiveness analysis of sacituzumab tirumotecan versus platinum-based chemotherapy as second-line treatment for progressed EGFR-mutant non-small-cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2026,35(5):553-562.
1435 times 271 times

JIN Lijun ZHANG Lele HAN Lu LYU Zhenye

Sacituzumab tirumotecan Non-small cell lung cancer EGFR mutation Quality adiusted life year Incremental Cost-effectiveness ratio Cost-effectiveness analysis Scenaio analysis
Details